Bill To Ease Restrictions On Controlled Substance Exports Clears House Commerce Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
Legislation that would remove certain export restrictions for controlled substances is now under review by the House Judiciary Committee. HR 184 would create “new parity” for U.S. pharmaceutical manufacturers, the bill’s sponsor says.
You may also be interested in...
Rx Controlled Substances Bills Head To President’s Desk
The bills would ease restrictions on exporting controlled substances and limitations on medical practices that treat drug-addicted patients.
Rx Controlled Substances Bills Head To President’s Desk
The bills would ease restrictions on exporting controlled substances and limitations on medical practices that treat drug-addicted patients.
Controlled Substances Export Reform Act Clears House Subcommittee
The bill would allow drug manufacturers to ship controlled substances to foreign sites for further export. Pennsylvania Congressman Pitts (R), who sponsored the legislation, says it will help small pharma companies keep jobs in the U.S.